{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:31:33Z","timestamp":1791286293822,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":172,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007888.pub2","type":"reference-entry","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T12:08:48Z","timestamp":1398773328000},"source":"Crossref","is-referenced-by-count":59,"title":["Stem cell therapy for chronic ischaemic heart disease and congestive heart failure"],"prefix":"10.1002","author":[{"given":"Sheila A","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J","family":"Brunskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enca","family":"Martin-Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,29]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD007888.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ncpcardio1321","article-title":"Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone","volume":"5","author":"Ang","year":"2008","journal-title":"Nature Clinical Practice. Cardiovascular Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007888.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007888.pub2-BIB3|cit3","series-title":"European Heart Journal","first-page":"282 Abstract P1","article-title":"Transcoronary transplantation of progenitor cells for left ventricular dysfunction after healed myocardial infarction: a direct comparison of different cell types (TOPCARE-CHD crossover trial)","author":"Assmus","year":"2006"},{"key":"10.1002\/14651858.CD007888.pub2-BIB4|cit4","series-title":"Circulation","first-page":"Abstract 3416","article-title":"Impaired microvascular function as a predictor of improvement in patients with chronic post-infarction heart failure receiving intracoronary progenitor cells - results of the TOPCARE-CHD Doppler substudy","author":"Bellera Gotarda","year":"2008"},{"key":"10.1002\/14651858.CD007888.pub2-BIB5|cit5","series-title":"Circulation","first-page":"Abstract 13050.","article-title":"Cardiac extracorporal shock wave application to enhance the efficiency of intracoronary cell therapy in chronic heart failure - Final results of the randomized, double-blind, placebo-controlled CELLWAVE trial","author":"Assmus","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB6|cit6","series-title":"Circulation","first-page":"Abstract 14838.","article-title":"Cardiac extracorporal shock wave-facilitated cell therapy in patients with chronic heart failure (Cellwave trial) - mechanistic insights by magnetic resonance imaging","author":"Steiner","year":"2012"},{"issue":"11","key":"10.1002\/14651858.CD007888.pub2-BIB7|cit7","first-page":"552","article-title":"Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery","volume":"18","author":"Chen","year":"2006","journal-title":"The Journal of Invasive Cardiology"},{"key":"10.1002\/14651858.CD007888.pub2-BIB8|cit8","series-title":"European Heart Journal","first-page":"532, Abstract P","article-title":"Intracoronary transplantation of circulating progenitor cells after recanalisation of chronic coronary artery occlusions: impact on coronary vasomotion and left ventricular remodelling","author":"Erbs","year":"2005"},{"issue":"8","key":"10.1002\/14651858.CD007888.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.RES.0000185811.71306.8b","article-title":"Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study","volume":"97","author":"Erbs","year":"2005","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD007888.pub2-BIB10|cit10","series-title":"European Heart Journal","first-page":"274, Abstract P","article-title":"Intracoronary infusion of blood-derived progenitor cells after recanalization of chronic coronary occlusions: long term effects on cardiac function and infarct size","author":"Erbs","year":"2006"},{"key":"10.1002\/14651858.CD007888.pub2-BIB11|cit11","series-title":"Circulation","first-page":"Abstract 3420.","article-title":"Effects on myocardial perfusion at 3 and 15 months in recanalized chronic total occlusions - randomized comparison of blood-derived progenitor cells and inactive serum","author":"Thiele","year":"2007"},{"key":"10.1002\/14651858.CD007888.pub2-BIB12|cit12","series-title":"Circulation","first-page":"Abstract 2616.","article-title":"Mechanistic insights from serial cardiac magnetic resonance imaging at 3 and 15 months after application of blood-derived progenitor cells in recanalized chronic coronary total occlusions (CTO)","author":"Thiele","year":"2006"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijcard.2008.03.055","article-title":"Cardiac magnetic resonance imaging at 3 and 15 months after application of circulating progenitor cells in recanalised chronic total occlusions","volume":"135","author":"Thiele","year":"2009","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD007888.pub2-BIB14|cit14","doi-asserted-by":"crossref","unstructured":"Hendrikx M Hensen K Clijsters C Jongen H Koninckx R Bijnens E Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial Circulation 2006 I101 7","DOI":"10.1161\/CIRCULATIONAHA.105.000505"},{"issue":"11","key":"10.1002\/14651858.CD007888.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3727\/096368912X654957","article-title":"G-CSF stimulation and coronary reinfusion of mobilized circulating mononuclear proangiogenic cells in patients with chronic ischemic heart disease: Five-year results of the TOPCARE-G-CSF trial","volume":"21","author":"Honold","year":"2012","journal-title":"Cell Transplantation"},{"issue":"24","key":"10.1002\/14651858.CD007888.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.jacc.2011.01.037","article-title":"Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial","volume":"57","author":"Hu","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD007888.pub2-BIB17|cit17","first-page":"969","article-title":"Assessment of therapeutic effects of stem cell transplantation in heart failure patients with old myocardial infarction by magnetic resonance imaging","volume":"36","author":"Lu","year":"2008","journal-title":"Chinese Journal of Cardiology"},{"issue":"24","key":"10.1002\/14651858.CD007888.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/eurheartj\/ehs231","article-title":"Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colong-stimulating factor in patients with myocardial infarction","volume":"33","author":"Kang","year":"2012","journal-title":"European Heart Journal"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD007888.pub2-BIB19|cit19","first-page":"I145","article-title":"Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial","volume":"114","author":"Kang","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD007888.pub2-BIB20|cit20","series-title":"Circulation","first-page":"Abstract A15621","article-title":"Randomized, double-blind, placebo-controlled trial of autologous CD34+ cell therapy for refractory angina: 2-year safety analysis","author":"Losordo","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB21|cit21","series-title":"Circulation","first-page":"Abstract 3361.","article-title":"Randomized, double-blind, placebo controlled pilot trial of intramyocardial autologous CD34 cell therapy for intractable angina","author":"Losordo","year":"2006"},{"issue":"25","key":"10.1002\/14651858.CD007888.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD007888.pub2-BIB23|cit23","series-title":"Circulation","first-page":"Abstract 12015.","article-title":"Clinical parameters influencing cell mobilization and impact of mobilization ability on efficacy outcomes: An analysis from ACT34-CMI","author":"Junge","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB24|cit24","series-title":"Blood","first-page":"Abstract 3227.","article-title":"Phase 2 study of intramyocardial injection of autologous CD34+ cells to treat subjects with refractory chronic myocardial ischemia (CMI): Factors influencing mobilization and apheresis","author":"Livingston","year":"2009"},{"key":"10.1002\/14651858.CD007888.pub2-BIB25|cit25","series-title":"Circuation","first-page":"Abstract 5638.","article-title":"Autologous CD34+ cell therapy for refractory angina: 12 month results of the phase II ACT34-CMI study","author":"Losordo","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD007888.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refrectory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD007888.pub2-BIB27|cit27","series-title":"Circulation","first-page":"Abstract 11770.","article-title":"Cardiac biomarker elevation during stem cell mobilisation, apheresis and intramyocardial delivery is common but does not impact incidence of long-term MACE: An analysis from ACT34-CMI","author":"Povsic","year":"2012"},{"issue":"5","key":"10.1002\/14651858.CD007888.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ahj.2012.06.022","article-title":"Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI","volume":"164","author":"Povsik","year":"2012","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jtcvs.2005.07.056","article-title":"Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study","volume":"130","author":"Patel","year":"2005","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"10.1002\/14651858.CD007888.pub2-BIB30|cit30","series-title":"Journal of the American College of Cardiology","first-page":"A193, Abstract","article-title":"FOCUS-HF: The first US randomized blinded controlled trial of transendocardial injection of bone marrow mononuclear cells in chronic severe ischemic heart failure patients","author":"Perin","year":"2009"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2011.01.028","article-title":"A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)","volume":"161","author":"Perin","year":"2011","journal-title":"American Heart Journal"},{"issue":"16","key":"10.1002\/14651858.CD007888.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ahj.2010.03.029","article-title":"Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design","volume":"160","author":"Willerson","year":"2010","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB34|cit34","series-title":"Circulation","first-page":"Abstract 3502.","article-title":"First in man transendocardial injection of autologous aldehyde dehydrogenase-bright cells in heart failure patients (FOCUS-Bright)","author":"Perin","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"415-21, 421.e1","DOI":"10.1016\/j.ahj.2011.11.020","article-title":"Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure","volume":"163","author":"Perin","year":"2012","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB36|cit36","series-title":"Journal of the American College of Cardiology","first-page":"A24: Abstract E","article-title":"Efficacy of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: Long term results: ACC poster contributions","author":"Pokushalov","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB37|cit37","series-title":"Journal of Cardiac Failure","first-page":"S44, Abstract 1","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: Long-term results","author":"Pokushalov","year":"2009"},{"key":"10.1002\/14651858.CD007888.pub2-BIB38|cit38","series-title":"American Journal of Cardiology","first-page":"74D - 75D, Abst","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: Long-term results","author":"Pokushalov","year":"2009"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12265-009-9123-8","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study","volume":"3","author":"Pokushalov","year":"2010","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"10.1002\/14651858.CD007888.pub2-BIB40|cit40","series-title":"European Heart Journal","first-page":"504, Abstract P","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: long-term results.","author":"Romanov","year":"2009"},{"key":"10.1002\/14651858.CD007888.pub2-BIB41|cit41","series-title":"Heart Rhythm","first-page":"S348: Abstract","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study","author":"Romanov","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB42|cit42","series-title":"European Journal of Heart Failure","first-page":"ii705, Abstract","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear stem cells in patients with ischemic heart failure: long-term results","author":"Romanov","year":"2009"},{"key":"10.1002\/14651858.CD007888.pub2-BIB43|cit43","series-title":"European Journal of Heart Failure","first-page":"S60-S61, Abstra","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study","author":"Romanov","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB44|cit44","series-title":"European Heart Journal","first-page":"323, Abstract 2","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study","author":"Romanov","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB45|cit45","series-title":"European Heart Journal","first-page":"591; Abstract 3","article-title":"Cardiac resynchronization therapy and bone marrow transplantation in patients with ischemic heart failure and electro-mechanical dyssynchrony. A randomized study","author":"Romanov","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB46|cit46","series-title":"Journal of the American College of Cardiology","first-page":"Abstract E241.","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study","author":"Romanov","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1532-429X-12-6","article-title":"Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease","volume":"12","author":"Chan","year":"2010","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"issue":"24","key":"10.1002\/14651858.CD007888.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/eurheartj\/ehm485","article-title":"Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial)","volume":"28","author":"Tse","year":"2007","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12015-010-9220-8","article-title":"Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease","volume":"7","author":"Turan","year":"2011","journal-title":"Stem Cell Reviews"},{"issue":"9","key":"10.1002\/14651858.CD007888.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1089\/scd.2010.0373","article-title":"Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease","volume":"20","author":"Turan","year":"2011","journal-title":"Stem Cells and Development"},{"issue":"5","key":"10.1002\/14651858.CD007888.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ahj.2012.08.008","article-title":"Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison","volume":"164","author":"Rodrigo","year":"2012","journal-title":"American Heart Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007888.pub2-BIB52|cit52","article-title":"Intramyocardial injection of bone marrow mononuclear cells in patients with chronic myocardial ischemia: An intra-patient comparison","volume":"124","author":"Rodrigo","year":"2011","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD007888.pub2-BIB53|cit53","series-title":"Circulation","first-page":"Abstract A15175","article-title":"Intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia: Results long term follow-up","author":"Rodrigo","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB54|cit54","series-title":"European Heart Journal","first-page":"820, Abstract P","article-title":"Intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia: Results long term follow-up","author":"Rodrigo","year":"2011"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCIMAGING.110.957548","article-title":"Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function","volume":"4","author":"Ramshorst","year":"2011","journal-title":"Circulation, Cardiovascular Imaging"},{"issue":"19","key":"10.1002\/14651858.CD007888.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2009.685","article-title":"Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial","volume":"301","author":"Ramshorst","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007888.pub2-BIB57|cit57","series-title":"European Heart Journal","first-page":"452, Abstract 2","article-title":"Intramyocardial injection of bone marrow-derived mononuclear cells for chronic myocardial ischemia: a randomized, double-blind, placebo-controlled trial","author":"Ramshorst","year":"2009"},{"key":"10.1002\/14651858.CD007888.pub2-BIB58|cit58","series-title":"Journal of the American College of Cardiology","first-page":"A340, Abstract","article-title":"Intramyocardial autologous bone marrow cell injection in no-option patients with refractory angina pectoris and documented ischemia: A randomized, double blinded, placebo-controlled trial","author":"Ramshorst","year":"2009"},{"issue":"14","key":"10.1002\/14651858.CD007888.pub2-BIB59|cit59","first-page":"2623","article-title":"Intracoronary transplantation with autologous bone marrow CD34+ stem cells for angina: a randomized controlled clinical analysis","volume":"13","author":"Wang","year":"2009","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000320217","article-title":"Intracoronary autologous CD34+ stem cell therapy for intractable angina","volume":"117","author":"Wang","year":"2010","journal-title":"Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD007888.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/hrt.2007.137919","article-title":"Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function","volume":"94","author":"Yao","year":"2008","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.athoracsur.2008.08.068","article-title":"Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery","volume":"86","author":"Zhao","year":"2008","journal-title":"The Annals of Thoracic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD007888.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"684.e11","DOI":"10.1016\/j.ahj.2006.07.018","article-title":"Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results","volume":"152","author":"Beeres","year":"2006","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB64|cit64","doi-asserted-by":"crossref","unstructured":"Beeres SL Bax JJ Zeppenfeld K Dibbets-Schneider P Stokkel MP Fibbe WE Feasibility of trans-endocardial cell transplantation in chronic ischaemia Heart (British Cardiac Society) 2007 113 4","DOI":"10.1136\/hrt.2005.084004"},{"issue":"7","key":"10.1002\/14651858.CD007888.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjcard.2007.04.056","article-title":"Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction","volume":"100","author":"Beeres","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD007888.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jacc.2006.10.072","article-title":"Role of imaging in cardiac stem cell therapy","volume":"49","author":"Beeres","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD007888.pub2-BIB67|cit67","series-title":"Circulation","first-page":"Abstract 2718.","article-title":"Restoration of synchronicity of the left ventricular myocardial contraction with stem cell therapy: New insights into the therapeiutic implication of stem cell therapy in myocardial infarction","author":"Chang","year":"2006"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1160\/TH09-08-0520","article-title":"Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study","volume":"103","author":"Charwat","year":"2010","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD007888.pub2-BIB69|cit69","series-title":"European Heart Journal","first-page":"79-80, Abstract","article-title":"Safety and efficacy of autologous mesenchymal stem cells for the treatment of end-stage dilated cardiomyopathy - a comparison of intracoronary and direct intramyocardial injection","author":"Chin","year":"2010"},{"issue":"4","key":"10.1002\/14651858.CD007888.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1253\/circj.CJ-10-0898","article-title":"Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure--a pilot study","volume":"75","author":"Gu","year":"2011","journal-title":"Circulation Journal"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3727\/096368912X636830","article-title":"Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up","volume":"22","author":"Haack-Sorensen","year":"2013","journal-title":"Cell Transplantation"},{"key":"10.1002\/14651858.CD007888.pub2-BIB72|cit72","series-title":"Heart Surgery Forum","first-page":"S121. 20th Worl","article-title":"Influence of bone-marrow derived progenitor stem cells on cardiac remodelling in a placebo-controlled clinical trial involving patients with congestive heart failure","author":"Kakuchaya","year":"2010"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4070\/kcj.2006.36.2.99","article-title":"Six months follow up results of \"granulocytes-colony stimulating factor\" based stem cell therapy in patients with myocardial infarction: MAGIC cell randomized controlled trial","volume":"36","author":"Kang","year":"2006","journal-title":"Korean Circulation Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB74|cit74","series-title":"European Journal of Heart Failure","first-page":"ii707","article-title":"Randomized controlled trial on the cario protective effect of bone marrow cells in patients undergoing coronary artery bypass graft surgery","author":"Ang","year":"2009"},{"issue":"19","key":"10.1002\/14651858.CD007888.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/eurheartj\/ehp262","article-title":"Randomized controlled trial on the cardioprotective effect of bone marrow cells in patients undergoing coronary bypass graft surgery","volume":"30","author":"Lai","year":"2009","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD007888.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/RLU.0b013e318251e38a","article-title":"Residual viability is a predictor of the perfusion enhancement obtained with the cell therapy of chronic myocardial infarction: a pilot multimodal imaging study","volume":"37","author":"Maureira","year":"2012","journal-title":"Clinical Nuclear Medicine"},{"issue":"18","key":"10.1002\/14651858.CD007888.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.CIR.0000070596.30552.8B","article-title":"Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure","volume":"107","author":"Perin","year":"2003","journal-title":"Circulation"},{"issue":"11 Suppl 1","key":"10.1002\/14651858.CD007888.pub2-BIB78|cit78","first-page":"II213","article-title":"Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy","volume":"110","author":"Perin","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD007888.pub2-BIB79|cit79","first-page":"477","article-title":"Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up","volume":"67","author":"Peruga","year":"2009","journal-title":"Kardiologia Polska"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12265-011-9283-1","article-title":"Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study","volume":"4","author":"Pokushalov","year":"2011","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"10.1002\/14651858.CD007888.pub2-BIB81|cit81","series-title":"Journal of the American College of Cardiology","first-page":"Abstract E103","article-title":"Cardiac resynchronization therapy in patients with ischemic heart failure after bone marrow cell transplantation","author":"Pokushalov","year":"2011"},{"issue":"5","key":"10.1002\/14651858.CD007888.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0218492310379939","article-title":"Bypass grafts and cell transplant in heart failure with low ejection fraction","volume":"18","author":"Rivas-Plata","year":"2010","journal-title":"Asian Cardiovascular & Thoracic Annals"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","article-title":"Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies","volume":"133","author":"Stamm","year":"2007","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"10.1002\/14651858.CD007888.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1479-5876-9-183","article-title":"Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina","volume":"9","author":"Tuma","year":"2011","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.carrev.2005.08.002","article-title":"One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina","volume":"6","author":"Vicario","year":"2005","journal-title":"Cardiovascular Revascularization Medicine : Including Molecular Interventions"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB86|cit86","first-page":"71","article-title":"Transcoronary sinus administration of autologous bone marrow in patients with chronic refractory stable angina Phase 1","volume":"5","author":"Vicario","year":"2004","journal-title":"Cardiovascular Radiation Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB87|cit87","first-page":"103","article-title":"[Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with anterior myocardial infarction]","volume":"34","author":"Wang","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1002\/14651858.CD007888.pub2-BIB88|cit88","series-title":"Circulation","first-page":"Abstract 18117.","article-title":"Cardiopoietic stem cell therapy in heart failure: The multicenter randomized c-cure trial","author":"Bartunek","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB89|cit89","series-title":"European Heart Journal","first-page":"815","article-title":"Cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy: First-in-man phase II multicentre clinical trial","author":"Bartunek","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB90|cit90","series-title":"Journal of the American College of Cardiology","first-page":"E200","article-title":"C-cure multicenter trial: Lineage specified bone marrow derived cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy","author":"Bartunek","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB91|cit91","series-title":"Bone Marrow Transplantation","first-page":"S215. European","article-title":"Progenitor cell trafficking in patients with infarcted myocardium undergoing autologous bone marrow mononuclear cell injection. Interim analysis of a double blind randomised phase II clinical trial","author":"Cuzzola","year":"2007"},{"key":"10.1002\/14651858.CD007888.pub2-BIB92|cit92","series-title":"European Heart Journal","first-page":"816: Abstract P","article-title":"Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients: The design of the PROGENITOR randomized trial","author":"Jimenez-Quevedo","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB93|cit93","series-title":"Circulation","first-page":"American Heart","article-title":"Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients: Preliminary 3-months results of the progenitor trial","author":"Jimenez-Quevedo","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB94|cit94","series-title":"Journal of the American College of Cardiology","first-page":"B112","article-title":"Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients: Preliminary results of safety and feasibility","author":"Jimenez-Quevedo","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB95|cit95","series-title":"European Heart Journal","first-page":"290: Abstract P","article-title":"Accurate design of randomized placebo-controlled clinical trials for assessment of stem cell effects on cardiac regeneration","author":"Kakuchaya","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB96|cit96","series-title":"Heart","first-page":"A137","article-title":"Effects of autologous bone marrow mononuclear cells transplantation through coronary artery bypass grafting in patients with old myocardial infarction assessed by MRI: A randomised, double-blind, placebo-controlled pilot trial","author":"Minjie","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB97|cit97","series-title":"Journal of the American College of Cardiology","first-page":"E864","article-title":"Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischemic myocardium: Results of the CARDIO133 trial","author":"Nasseri","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB98|cit98","series-title":"Interactive Cardiovascular and Thoracic Surgery","first-page":"S233. 3rd EACTS","article-title":"Improved regional contractile function and reduced scar size after clinical cell therapy with CD133-positive cells","author":"Nasseri","year":"2013"},{"key":"10.1002\/14651858.CD007888.pub2-BIB99|cit99","series-title":"Heart","first-page":"E42","article-title":"Intracoronary autologous CD34+ stem cell therapy for intractable angina","author":"Shihong","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB100|cit100","series-title":"Journal of the American College of Cardiology","first-page":"B71","article-title":"Long term benefit of autologous bone marrow transplantation by retrograde technique in terminal heart failure (LIBERTY study)","author":"Tuma","year":"2010"},{"key":"10.1002\/14651858.CD007888.pub2-BIB101|cit101","series-title":"European Heart Journal","first-page":"276: Abstract P","article-title":"Improvement of cardiomyocyte function after transplantation of autologous bone marrow mesenchymal stem cells in patients with non-acute ischemic heart disease","author":"Zverev","year":"2006"},{"key":"10.1002\/14651858.CD007888.pub2-BIB102|cit102","unstructured":"ACTRN12611000219987 A study of the effect of direct endomyocardial injection of autologous bone marrow cells on left ventricular ejection function in patients with \"end-stage\" ischaemic heart failure apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12611000219987"},{"key":"10.1002\/14651858.CD007888.pub2-BIB103|cit103","unstructured":"EUCTR2009-016364-36-NL Injection of autologous bone marrow cells into damaged myocardium of no-option patients with ischemic heart failure: a randomized placebo controlled trail. - Cell therapy for ischemic heart failure apps.who.int\/trialsearch\/trial.aspx?trialid=EUCTR2009-016364-36-NL"},{"key":"10.1002\/14651858.CD007888.pub2-BIB104|cit104","unstructured":"EUCTR2011_001117-13-GB Research study aiming at investigating the potential effectiveness and safety of a treatment for chronic advanced heart failure of ischemic origin. The treatment is based on patient own stem cells that will be collected and guided to the cardiac cells lineage before being injected into the heart muscle apps.who.int\/trialsearch\/trial.aspx?trialid=EUCTR2011-001117-13-GB"},{"key":"10.1002\/14651858.CD007888.pub2-BIB105|cit105","unstructured":"ISRCTN71717097 Bone-marrow derived stem cell transplantation in patients undergoing left ventricular restoration surgery for dilated ischaemic end-stage heart failure: a randomised blinded controlled trial (TransACT 2) apps.who.int\/trialsearch\/Trial.aspx?TrialID=ISRCTN71717097"},{"key":"10.1002\/14651858.CD007888.pub2-BIB106|cit106","unstructured":"ISRCTN75217135 A pilot study to evaluate the efficacy of combined transplantation of progenitor cells and coronary artery bypass grafting (TOPCABG) N\/A apps.who.int\/trialsearch\/trial.aspx?trialid=ISRCTN75217135"},{"key":"10.1002\/14651858.CD007888.pub2-BIB107|cit107","unstructured":"NCT00285454 Cell repair in heart failure clinicaltrials.gov\/show\/NCT00285454"},{"key":"10.1002\/14651858.CD007888.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-6215-8-2","article-title":"Multicenter randomized trial of cell therapy in cardiopathies - MiHeart study","volume":"8","author":"Tura","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD007888.pub2-BIB109|cit109","unstructured":"NCT00418418 Combined CABG and stem-cell transplantation for heart failure clinicaltrials.gov\/show\/NCT00418418"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2012.05.026","article-title":"Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)","volume":"164","author":"Mathiasen","year":"2012","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB111|cit111","unstructured":"NCT00690209 By pass surgery with stem cell therapy in chronic ischemic cardiopathy clinicaltrials.gov\/show\/NCT00690209"},{"key":"10.1002\/14651858.CD007888.pub2-BIB112|cit112","series-title":"European Heart Journal","first-page":"456. European S","article-title":"Head-to-head comparison of different delivery methods of autologous bone marrow progenitor cells in chronic ischaemic heart failure","author":"Mozid","year":"2011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB113|cit113","series-title":"American Journal of Cardiology","first-page":"190D","article-title":"Ejection fraction and NYHA class in heart failure in the REGENERATE-IHD stem cell study: A comparison between the intramyocardial intracoronary arms","author":"Yeo","year":"2009"},{"issue":"1","key":"10.1002\/14651858.CD007888.pub2-BIB114|cit114","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/17460751.4.1.119","article-title":"Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial","volume":"4","author":"Yeo","year":"2009","journal-title":"Regenerative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB115|cit115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ahj.2010.11.024","article-title":"Rational and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy","volume":"161","author":"Trachtenberg","year":"2011","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB116|cit116","unstructured":"NCT00790764 Phase II combination stem cell therapy for the treatment of severe coronary ischemia (CI) clinicaltrials.gov\/show\/NCT00790764"},{"key":"10.1002\/14651858.CD007888.pub2-BIB117|cit117","unstructured":"NCT00820586 Intramyocardial delivery of autologous bone marrow clinicaltrials.gov\/show\/NCT00820586"},{"key":"10.1002\/14651858.CD007888.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1745-6215-13-99","article-title":"Validating intramyocardial bone marrow stem cell therapy in combination with coronary artry bypass grafting, the PERFECT Phase III randomized multicentre trial: study protocol for a randomized controlled trial","volume":"13","author":"Donndorf","year":"2012","journal-title":"Trials"},{"key":"10.1002\/14651858.CD007888.pub2-BIB119|cit119","unstructured":"NCT01033617 IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG clinicaltrials.gov\/show\/NCT01033617"},{"key":"10.1002\/14651858.CD007888.pub2-BIB120|cit120","unstructured":"NCT01074099 Feasibility study of BMAC enhanced CABG clinicaltrials.gov\/show\/NCT01074099"},{"key":"10.1002\/14651858.CD007888.pub2-BIB121|cit121","unstructured":"NCT01150175 Direct endomyocardial injection of autologous bone marrow cells to treat ischaemic heart failure (END-HF) clinicaltrials.gov\/show\/NCT01150175"},{"key":"10.1002\/14651858.CD007888.pub2-BIB122|cit122","unstructured":"NCT01214499 Prospective, controlled and randomized clinical trial on cardiac cell regeneration with laser and autologous bone marrow stem Cclls, in patients with coronary disease and refractory angina clinicaltrials.gov\/show\/NCT01214499"},{"key":"10.1002\/14651858.CD007888.pub2-BIB123|cit123","unstructured":"NCT01267331 Cell therapy in patients with chronic ischemic heart disease undergoing cardiac surgery clinicaltrials.gov\/show\/NCT01267331"},{"key":"10.1002\/14651858.CD007888.pub2-BIB124|cit124","unstructured":"NCT01299324 Retrograde delivery of BMAC (bone marrow aspirate concentrate) for congestive heart failure clinicaltrials.gov\/show\/NCT01299324"},{"key":"10.1002\/14651858.CD007888.pub2-BIB125|cit125","unstructured":"NCT01337011 Intra-coronary versus intramyocardial application of enriched CD133pos autologous bone marrow derived stem cells (AlsterMACS) clinicaltrials.gov\/show\/NCT01337011"},{"key":"10.1002\/14651858.CD007888.pub2-BIB126|cit126","unstructured":"NCT01354678 Intramyocardial multiple precision injection of bone marrow mononuclear cells in myocardial ischemia (IMPI) clinicaltrials.gov\/show\/NCT01354678"},{"key":"10.1002\/14651858.CD007888.pub2-BIB127|cit127","unstructured":"NCT01442129 The effect of intramyocardial injection of mesenchymal precursor cells on myocardial function in patients undergoing LVAD implantation clinicaltrials.gov\/ct2\/show\/NCT01442129"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ahj.2013.03.003","article-title":"A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study","volume":"165","author":"Povsic","year":"2013","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD007888.pub2-BIB129|cit129","series-title":"Circulation","first-page":"Abstract 11777.","article-title":"A phase 3, randomized, partially blinded, active-controlled, study assessing the efficacy and safety of intramyocaridal autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study","author":"Povsic","year":"2012"},{"key":"10.1002\/14651858.CD007888.pub2-BIB130|cit130","unstructured":"NCT01615250 Implantation of peripheral stem cells in patient with ischemic cardiomyopathy (ISCIC) clinicaltrials.gov\/show\/NCT01615250"},{"key":"10.1002\/14651858.CD007888.pub2-BIB131|cit131","unstructured":"NCT01660581 Intracardiac CD133+ cells in patients with no-option resistant angina (Regent Vsel) clinicaltrials.gov\/show\/NCT01660581"},{"key":"10.1002\/14651858.CD007888.pub2-BIB132|cit132","unstructured":"NCT01666132 METHOD - Bone marrow derived mononuclear cells in chronic ischemic disease clinicaltrials.gov\/show\/NCT01666132"},{"key":"10.1002\/14651858.CD007888.pub2-BIB133|cit133","unstructured":"NCT01727063 Cell therapy in severe chronic ischemic heart disease (MiHeart) clinicaltrials.gov\/show\/NCT01727063"},{"key":"10.1002\/14651858.CD007888.pub2-BIB134|cit134","unstructured":"NCT01768702 Safety and efficacy of autologous cardiopoietic cells for treatment of ischemic heart failure. (CHART-1) clinicaltrials.gov\/show\/NCT01768702"},{"key":"10.1002\/14651858.CD007888.pub2-BIB135|cit135","unstructured":"NTR2516 Injection of autologous bone marrow cells into damaged myocardium of no-option patients with ischemic heart failure, a randomized placebo-controlled trial apps.who.int\/trialsearch\/trial.aspx?trialid=NTR2516"},{"issue":"9580","key":"10.1002\/14651858.CD007888.pub2-BIB136|cit136","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(07)60992-1","article-title":"Cell therapy in myocardial infarction","volume":"369","author":"Arnesen","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD007888.pub2-BIB137|cit137","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.0000043246.74879.CD","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)","volume":"106","author":"Assmus","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD007888.pub2-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmuss","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB139|cit139","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1002\/14651858.CD007888.pub2-BIB140|cit140","unstructured":"British Heart Foundation Coronary Heart Disease statistics www.heartstats.org (last updated 27th March 2009)"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB141|cit141","doi-asserted-by":"crossref","first-page":"H533","DOI":"10.1152\/ajpheart.00094.2008","article-title":"Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study","volume":"295","author":"Carr","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB142|cit142","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006536.pub3","article-title":"Stem cell treatment for acute myocardial infarction","author":"Clifford","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007888.pub2-BIB143|cit143","doi-asserted-by":"crossref","first-page":"e37373","DOI":"10.1371\/journal.pone.0037373","article-title":"Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes","volume":"7","author":"Clifford","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB144|cit144","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0735-1097(03)00911-2","article-title":"Outcomes of optimal or \"stent-like\" balloon angioplasty in acutemyocardial infarction: the CADILLAC trial","volume":"42","author":"Cox","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD007888.pub2-BIB145|cit145","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.0000061910.39145.F0","article-title":"Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients","volume":"107","author":"Deb","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB146|cit146","doi-asserted-by":"crossref","first-page":"e64669","DOI":"10.1371\/journal.pone.0064669","article-title":"Bone marrow stem cell treatment for ischemic heart disease patients with no option of revascularization: a systematic review and meta-analysis","volume":"8","author":"Fisher","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB147|cit147","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/ehp536","article-title":"Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation","volume":"31","author":"Grajek","year":"2010","journal-title":"European Heart Journal"},{"issue":"26","key":"10.1002\/14651858.CD007888.pub2-BIB148|cit148","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","article-title":"Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent primary angioplasty in myocardial infarction study group","volume":"341","author":"Grines","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD007888.pub2-BIB149|cit149","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007888.pub2-BIB150|cit150","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"9505","key":"10.1002\/14651858.CD007888.pub2-BIB151|cit151","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD007888.pub2-BIB152|cit152","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.111.086074","article-title":"Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis","volume":"126","author":"Jeevanantham","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD007888.pub2-BIB153|cit153","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB154|cit154","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1423-0410.2008.01076.x","article-title":"5-Azacytidine-treated human mesenchymal stem\/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies","volume":"95","author":"Martin-Rendon","year":"2008","journal-title":"Vox Sanguinis"},{"issue":"15","key":"10.1002\/14651858.CD007888.pub2-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehn220","article-title":"Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review","volume":"29","author":"Martin-Rendon","year":"2008","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD007888.pub2-BIB156|cit156","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006536.pub2","article-title":"Stem cell treatment for acute myocardial infarction","author":"Martin-Rendon","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9429","key":"10.1002\/14651858.CD007888.pub2-BIB157|cit157","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(04)16632-4","article-title":"Stem cells and repair of the heart","volume":"364","author":"Mathur","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD007888.pub2-BIB158|cit158","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial","volume":"113","author":"MeyerGP","year":"2006","journal-title":"Circulation"},{"issue":"6829","key":"10.1002\/14651858.CD007888.pub2-BIB159|cit159","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"issue":"18","key":"10.1002\/14651858.CD007888.pub2-BIB160|cit160","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1073\/pnas.181177898","article-title":"Mobilized bone marrow cells repair the infarcted heart, improving function and survival","volume":"98","author":"Orlic","year":"2001","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"6","key":"10.1002\/14651858.CD007888.pub2-BIB161|cit161","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jtcvs.2005.07.056","article-title":"Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study","volume":"130","author":"Patel","year":"2006","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"10.1002\/14651858.CD007888.pub2-BIB162|cit162","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.2 2012"},{"issue":"12","key":"10.1002\/14651858.CD007888.pub2-BIB163|cit163","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Sch\u00e4chinger","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD007888.pub2-BIB164|cit164","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"issue":"9351","key":"10.1002\/14651858.CD007888.pub2-BIB165|cit165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(03)12110-1","article-title":"Autologous bone marrow-derived stem cell transplantation for myocardial infarction","volume":"361","author":"Stamm","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007888.pub2-BIB166|cit166","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","article-title":"Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies","volume":"133","author":"Stamm","year":"2007","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD007888.pub2-BIB167|cit167","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0735-1097(97)00439-7","article-title":"Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30 day results of the PAMI stent pilot trial. Primary angioplasty in myocardial infarction stent pilot trial investigators","volume":"31","author":"Stone","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD007888.pub2-BIB168|cit168","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD007888.pub2-BIB169|cit169","first-page":"1913","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","journal-title":"2002"},{"issue":"8","key":"10.1002\/14651858.CD007888.pub2-BIB170|cit170","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1634\/stemcells.2006-0074","article-title":"Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart","volume":"24","author":"Stuckey","year":"2006","journal-title":"Stem Cells"},{"issue":"4","key":"10.1002\/14651858.CD007888.pub2-BIB171|cit171","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ahj.2011.06.019","article-title":"Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging","volume":"162","author":"Traverse","year":"2011","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD007888.pub2-BIB172|cit172","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI200522326","article-title":"Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction","volume":"115","author":"Yoon","year":"2005","journal-title":"Journal of Clinical Investigation"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007888.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T00:00:00Z","timestamp":1482537600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007888.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:14:51Z","timestamp":1628547291000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007888.pub2"}},"subtitle":[],"editor":[{"given":"Enca","family":"Martin-Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,29]]},"references-count":172,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007888.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007888.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2014,4,29]]}}}